Rothschild Investment LLC’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$491 Buy
119
+108
+982% +$466 ﹤0.01% 3266
2026
Q1
$41 Buy
+11
New +$46 ﹤0.01% 3483
2025
Q2
Sell
-30
Closed -$244 3154
2025
Q1
$244 Sell
30
-115
-79% -$1.07K ﹤0.01% 2804
2024
Q4
$1.86K Buy
145
+115
+383% +$1.36K ﹤0.01% 1846
2024
Q3
$322 Buy
30
+15
+100% +$141 ﹤0.01% 2598
2024
Q2
$119 Buy
+15
New +$143 ﹤0.01% 2676

Other funds holding RCEL

Rothschild Investment LLC's RCEL Position: Q2 2026 in Review

Rothschild Investment LLC increased its Avita Medical (RCEL) stake by 982% in Q2 2026, buying an estimated $466 and bringing the position to 119 shares worth $491. The position accounts for ﹤0.01% of the portfolio, ranked #3266.

Rothschild Investment LLC first reported a position in RCEL in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.86K in Q4 2024. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Rothschild Investment LLC held 119 shares of Avita Medical worth $491 as of Q2 2026.
  • Rothschild Investment LLC bought 108 Avita Medical shares in Q2 2026, an estimated $466.
  • Avita Medical made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3266 holding.
  • Rothschild Investment LLC first reported a position in Avita Medical in Q2 2024 and has held it in 6 quarters since.
  • Rothschild Investment LLC's Avita Medical position peaked at $1.86K in Q4 2024.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.